FR1555454A - - Google Patents

Info

Publication number
FR1555454A
FR1555454A FR1555454DA FR1555454A FR 1555454 A FR1555454 A FR 1555454A FR 1555454D A FR1555454D A FR 1555454DA FR 1555454 A FR1555454 A FR 1555454A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9758/60A external-priority patent/GB905694A/en
Application filed filed Critical
Application granted granted Critical
Publication of FR1555454A publication Critical patent/FR1555454A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR1555454D 1960-03-18 1961-03-15 Expired FR1555454A (US20110009641A1-20110113-C00256.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9758/60A GB905694A (en) 1960-03-18 1960-03-18 6-trifluoromethylsteroids and method for their production
GB2019060 1960-06-08

Publications (1)

Publication Number Publication Date
FR1555454A true FR1555454A (US20110009641A1-20110113-C00256.png) 1969-01-31

Family

ID=26243151

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1555454D Expired FR1555454A (US20110009641A1-20110113-C00256.png) 1960-03-18 1961-03-15

Country Status (5)

Country Link
AT (1) AT248619B (US20110009641A1-20110113-C00256.png)
BE (1) BE601534A (US20110009641A1-20110113-C00256.png)
CH (1) CH399446A (US20110009641A1-20110113-C00256.png)
ES (1) ES265825A1 (US20110009641A1-20110113-C00256.png)
FR (1) FR1555454A (US20110009641A1-20110113-C00256.png)

Also Published As

Publication number Publication date
ES265825A1 (es) 1961-10-16
BE601534A (fr) 1961-09-20
AT248619B (de) 1966-08-10
CH399446A (de) 1965-09-30

Similar Documents

Publication Publication Date Title
IT649860A (US20110009641A1-20110113-C00256.png)
FI40557B (US20110009641A1-20110113-C00256.png)
DE1435451B2 (US20110009641A1-20110113-C00256.png)
DE1234212C2 (US20110009641A1-20110113-C00256.png)
DE1160947C2 (US20110009641A1-20110113-C00256.png)
JPS3728627Y1 (US20110009641A1-20110113-C00256.png)
DE1139823C2 (US20110009641A1-20110113-C00256.png)
FR1555454A (US20110009641A1-20110113-C00256.png)
IT649517A (US20110009641A1-20110113-C00256.png)
BE606561A (US20110009641A1-20110113-C00256.png)
BE603293A (US20110009641A1-20110113-C00256.png)
CH1034461A4 (US20110009641A1-20110113-C00256.png)
BE646916A (US20110009641A1-20110113-C00256.png)
BE637933A (US20110009641A1-20110113-C00256.png)
BE611686A (US20110009641A1-20110113-C00256.png)
BE610698A (US20110009641A1-20110113-C00256.png)
BE610442A (US20110009641A1-20110113-C00256.png)
BE609624A (US20110009641A1-20110113-C00256.png)
BE609577A (US20110009641A1-20110113-C00256.png)
BE609522A (US20110009641A1-20110113-C00256.png)
BE608300A (US20110009641A1-20110113-C00256.png)
BE608250A (US20110009641A1-20110113-C00256.png)
BE607558A (US20110009641A1-20110113-C00256.png)
BE606872A (US20110009641A1-20110113-C00256.png)
BE602856A (US20110009641A1-20110113-C00256.png)

Legal Events

Date Code Title Description
ST Notification of lapse